242 related articles for article (PubMed ID: 28422137)
21. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
22. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
23. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
24. Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.
He F; Kiener TK; Lim XF; Tan Y; Raj KV; Tang M; Chow VT; Chen Q; Kwang J
PLoS One; 2013; 8(1):e55517. PubMed ID: 23383215
[TBL] [Abstract][Full Text] [Related]
25. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.
Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z
Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105
[TBL] [Abstract][Full Text] [Related]
26. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.
Ding Y; Chen X; Qian B; Wu G; He T; Feng J; Gao C; Wang L; Wang J; Li X; Cao M; Peng H; Zhao C; Pan W
Sci Rep; 2015 May; 5():10636. PubMed ID: 26023863
[TBL] [Abstract][Full Text] [Related]
28. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides.
Li X; Mao C; Ma S; Wang X; Sun Z; Yi Y; Guo M; Shen X; Sun L; Bi S
Biochem Biophys Res Commun; 2009 Dec; 390(4):1126-8. PubMed ID: 19799860
[TBL] [Abstract][Full Text] [Related]
29. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
Ye X; Fan C; Ku Z; Zuo T; Kong L; Zhang C; Shi J; Liu Q; Chen T; Zhang Y; Jiang W; Zhang L; Huang Z; Cong Y
PLoS Pathog; 2016 Mar; 12(3):e1005454. PubMed ID: 26938634
[TBL] [Abstract][Full Text] [Related]
31. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
[TBL] [Abstract][Full Text] [Related]
32. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
33. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin.
Wu CY; Wang HC; Wang KT; Weng SC; Chang WH; Shih DY; Lo CF; Wang DY
Biologicals; 2013 May; 41(3):154-7. PubMed ID: 23515089
[TBL] [Abstract][Full Text] [Related]
35. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
[TBL] [Abstract][Full Text] [Related]
36. Antiviral Activity of a Llama-Derived Single-Domain Antibody against Enterovirus A71.
Huang PN; Wang HC; Hung HC; Tseng SN; Chang TY; Chou MY; Chen YJ; Wang YM; Shih SR; Hsu JT
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152074
[TBL] [Abstract][Full Text] [Related]
37. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.
Fujii K; Sudaka Y; Takashino A; Kobayashi K; Kataoka C; Suzuki T; Iwata-Yoshikawa N; Kotani O; Ami Y; Shimizu H; Nagata N; Mizuta K; Matsuzaki Y; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848582
[TBL] [Abstract][Full Text] [Related]
38. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
[TBL] [Abstract][Full Text] [Related]
39. Efficient Humoral and Cellular Immune Responses Induced by a Chimeric Virus-like Particle Displaying the Epitope of EV71 without Adjuvant.
Liang P; Yi Y; Su QD; Qiu F; Fan XT; Lu XX; Bi SL
Biomed Environ Sci; 2018 May; 31(5):343-350. PubMed ID: 29866216
[TBL] [Abstract][Full Text] [Related]
40. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
Zhou B; Xu L; Zhu R; Tang J; Wu Y; Su R; Yin Z; Liu D; Jiang Y; Wen C; You M; Dai L; Lin Y; Chen Y; Yang H; An Z; Fan C; Cheng T; Luo W; Xia N
Antiviral Res; 2019 Jan; 161():28-35. PubMed ID: 30419253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
